2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–2576.
6. Bidkhori G, Benfeitas R, Klevstig M, Zhang C, Nielsen J, Uhlen M,
et al. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes. Proc Natl Acad Sci U S A 2018;115:E11874–E11883.
7. Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM,
et al. Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma. Cancer Cell 2017;32:57–70.
11. Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT,
et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 2014;159:1665–1680.
14. Sexton T, Yaffe E, Kenigsberg E, Bantignies F, Leblanc B, Hoichman M,
et al. Three-dimensional folding and functional organization principles of the
Drosophila genome. Cell 2012;148:458–472.
15. Merkenschlager M, Nora EP. CTCF and cohesin in genome folding and transcriptional gene regulation. Annu Rev Genomics Hum Genet 2016;17:17–43.
18. Zhan Y, Mariani L, Barozzi I, Schulz EG, Bluthgen N, Stadler M,
et al. Reciprocal insulation analysis of Hi-C data shows that TADs represent a functionally but not structurally privileged scale in the hierarchical folding of chromosomes. Genome Res 2017;27:479–490.
20. Durand NC, Shamim MS, Machol I, Rao SS, Huntley MH, Lander ES,
et al. Juicer provides a one-click system for analyzing loop-resolution Hi-C experiments. Cell Syst 2016;3:95–98.
21. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011;17:10–2.
25. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S,
et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15–21.
28. Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat 2011;3:180–185.
30. Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013;14:178–192.
31. Qiu Z, Li H, Zhang Z, Zhu Z, He S, Wang X,
et al. A pharmacogenomic landscape in human liver cancers. Cancer Cell 2019;36:179–193.
37. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A,
et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009;326:289–293.
38. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E,
et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007;45:42–52.
41. Caruso S, Calatayud AL, Pilet J, La Bella T, Rekik S, Imbeaud S,
et al. Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response. Gastroenterology 2019;157:760–776.
44. Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol 2022;86:622–632.
45. Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 2014;342:223–230.
46. Munoz JJ, Drigo SA, Barros-Filho MC, Marchi FA, Scapulatempo-Neto C, Pessoa GS,
et al. Down-regulation of SLC8A1 as a putative apoptosis evasion mechanism by modulation of calcium levels in penile carcinoma. J Urol 2015;194:245–251.
47. He H, Wu S, Ai K, Xu R, Zhong Z, Wang Y,
et al. LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca(2+) concentration via transcription factor GATA6. Cell Oncol (Dordr) 2021;44:219–233.
48. Diaz-Horta O, Van Eylen F, Herchuelz A. Na/Ca exchanger overexpression induces endoplasmic reticulum stress, caspase-12 release, and apoptosis. Ann N Y Acad Sci 2003;1010:430–432.